As autumn and winter approach, the prevalence of respiratory infections increases significantly. With the colder temperatures, people spend more time indoors with less ventilation. This obviously [...]
Analysis of stool samples is a frequent task in clinical diagnostics. Heike Calado Duarte and Carlo Farah from our R&D team talk to us about the challenges involved and what you should pay [...]
Respiratory diseases often show similar symptoms, but are triggered by a variety of pathogens, such as viruses, bacteria and fungi. Rapid, comprehensive and reliable diagnostics as a basis for [...]
The bacteria Clostridium difficile colonizes every human intestine, although it may be harmful for those with compromised immune systems. It is becoming increasingly prevalent in hospitals. What [...]
Studies have shown that some patients do not respond or respond inadequately to therapies for chronic intestinal diseases like for example Inflammatory Bowel Disease. The biologic drug [...]
Therapeutic drug monitoring (TDM) for the biological Vedolizumab has not been in focus to date. Vedolizumab is a meant or the treatment for inflammatory bowel disease. On Wednesday, September 29, [...]
For World IBD Day we would like to draw your attention to the Inflammatory Bowel Disease (IBD). About ten million people worldwide (around three million in Europe) suffer from this chronic [...]
The COVID-19 infection figures continue to rise and with them the fear: How long can regular school operations be maintained? Experts warn of renewed school closings and recommend specific measures.
Helicobacter pylori can cause serious diseases. The symptoms of a Helicobacter infection vary widely in their form and expression. Detection is therefore critical for diagnosis and treatment. [...]
In February 2020, R-Biopharm was one of the first diagnostics companies worldwide to launch a test kit for the novel coronavirus SARS-CoV-2. Now, the test has received the CE label and is thus [...]